Effect of nesiritide on length of hospital stay in patients with decompensated heart failure

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 9, Issue 3, 2004, Pages 173-177

  Chang, Richard ^a   Elatre, Wafaa A ^a   Heywood, J Thomas ^a  

^a LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Congestive heart failure; Length of hospital stay; Nesiritide

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; DOPAMINE; FUROSEMIDE; MILRINONE; NESIRITIDE; NITRATE; SPIRONOLACTONE; UREA; WARFARIN;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; FEMALE; FLUID BALANCE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY FUNCTION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QRS COMPLEX; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL; WEIGHT REDUCTION;

AGED; AGED, 80 AND OVER; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; KIDNEY; LENGTH OF STAY; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; RETROSPECTIVE STUDIES;

EID: 4944242954     PISSN: 10742484     EISSN: None     Source Type: Journal    
DOI: 10.1177/107424840400900304     Document Type: Article

References (11)

1. American Heart Association 2003 Heart Stroke Statistical Update.
2. Parmley W. Pathophysiology and current treatment for congestive heart failure. J Amer Coll Cardiol 13:771-785, 1989.
3. Kozak LJ, Hall MJ, Owings MF. National Hospital Discharge Survey: 2000 Annual Summary with detailed diagnosis and procedure data. National Center for Health Statistics. Vital Health Stat 13 (153):1-194, 2002
4. Rich MS, Beckham V, Wittenberg C, et al. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 333:1190-1195, 1995
5. O'Connell JB, Bristow MR. Economic impact of heart failure in the United States: Time for a different approach J Heart Lung Transplant 13:S107-S112, 1994
6. Smith GL, Vaccarino V, Kosiborod M, et al. Worsening renal function: What is a clinically meaningful change in creatinine during hospitalizations with heart failure. J Card Failure 2:13-18, 2003
7. 1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Circulation 105:1348-1353, 2002
8. Ellison DH. Diuretic drugs and the treatment of edema: From clinic to bench and back again. Am J Kidney Dis 23:623-643, 1994
9. Publication Committee for the VMAC Investigators. Intravenous nesiritide vs. nitroglycerin for treatment of decompensated congestive heart failure: A randomized controlled trial. JAMA 287:1531-1540, 2002
10. Marcus LS, Hart D, Packer M, et al. Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure. A double-blind, placebo-controlled, randomized crossover trial. Circulation 94:3184-3189, 1996
11. Gottlieb SS, Abraham WT, Butler J, et al. The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Cardiac Failure 8:136-141, 2002